Labcorp, Pillar Biosciences team up for genomic testing
October 19, 2021 -- Labcorp and Pillar Biosciences have signed an agreement to offer genomic cancer testing based on Pillar's next-generation sequencing technology. Read More
Natera unveils lung transplant assessment test
October 19, 2021 -- Cell-free DNA testing company Natera has introduced its Prospera transplant assessment test for lung transplant recipients. Read More
Eurofins lands $30M COVID diagnostic testing contract
October 18, 2021 -- Eurofins Genomics has won a $30 million contract with the U.S. Department of Air Force and the U.S. Department of Health and Human Services to build a new production facility for manufacturing reagents used in COVID-19 diagnostic tests. Read More
Stilla launches Naica 6-color digital PCR system
October 18, 2021 -- Stilla Technologies has launched Naica, a digital polymerase chain reaction (PCR) system that features six fluorescent channels. Naica was introduced at the American Society of Human Genetics virtual meeting. Read More
PathAI partners with Roche for AI tech
October 15, 2021 -- PathAI and Roche are partnering to develop and distribute PathAI's artificial intelligence (AI)-powered technology through Roche's uPath enterprise software. Read More
Illumina appoints Ragusa as CEO of Grail
October 15, 2021 -- Illumina has appointed Bob Ragusa as CEO of Grail, which currently operates as a separate and independent unit of Illumina after its August acquisition. Read More
Gestalt debuting new version of PathFlow
October 15, 2021 -- Gestalt Diagnostics will debut the latest version of its PathFlow pathology software during the Pathology Visions Conference to be held October 17-20 in Las Vegas and hosted by the Digital Pathology Association. Read More
Quest Diagnostics debuts new lab facility in NJ
October 14, 2021 -- Quest Diagnostics has finished integrating its Northeast regional operations into a new 25,000-sq-ft, next-generation lab facility in Clifton, NJ. Read More
Agilent receives FDA approval for breast cancer assay
October 14, 2021 -- Agilent Technologies has received approval from the U.S. Food and Drug Administration (FDA) for its Ki-67 IHC MIB-1 pharmDx assay. The assay can help identify patients with early breast cancer who are at high risk of disease recurrence. Read More
Prenosis, Roche expand partnership to combat sepsis
October 14, 2021 -- Prenosis and Roche Diagnostics will expand their existing partnership with a $6 million infusion to improve and expedite the clinical identification of sepsis through advanced precision diagnostics. Read More